Ribosome-associated quality control (RQC) pathways monitor and respond to ribosome stalling. Using in vivo UV-crosslinking and mass spectrometry, we identified a C-terminal region in Hel2/Rqt1 as an RNA binding domain. Complementary crosslinking and sequencing data for Hel2 revealed binding to 18S rRNA and translated mRNAs. Hel2 preferentially bound mRNAs upstream and downstream of the stop codon. C-terminal truncation of Hel2 abolished the major 18S crosslink and polysome association, and altered mRNA binding.
This process removes damaged proteins
HEL2 deletion caused loss of RQC and, we report here, no-go decay (NGD), with comparable effects for Hel2 truncation including the RNA-binding site. Firstly, Asc1 acts upstream of Hel2 in RQC and asc1∆ impaired Hel2 binding to 18S and mRNA. In conclusion, Hel2 has it’s recruitment or stabilization on translating 40S ribosomal subunits by interactions with 18S rRNA and Asc1. This 18S interaction; required for Hel2 function in RQC and NGD. Hel2 probably interacts with mRNA during translation termination.
Scientists have shed light on a biological process that helps the production of healthy cells, which may aid understanding of neurological diseases and other conditions. Researchers examined a housekeeping mechanism which removes faulty proteins as they form. This process, which is common to many living things, removes damaged proteins, preventing their accumulation in cells, tissues and organs.
“The process of removing stalled proteins”
So, the team concentrated on a part of this mechanism that removes proteins; that become stalled part way through their formation. This clears the way for further production of protein. Scientists studied a yeast protein known as Hel2, using UV light to identify where this protein touches molecules involved in protein production. These interactions help Hel2 identify flaws in protein formation.
When researchers removed the parts of Hel2 in direct contact, this prevented the destruction of faulty proteins, showing that these contacts are important for the mechanism. Partly formed proteins can not only be dysfunctional but may be toxic, for example when they form protein clumps resembling those associated with Alzheimer’s or Parkinson’s.
Above all, the study, published in Nature Communications, was supported by the European Molecular Biology Organisation and Wellcome. Dr Marie-Luise Winz, of the University of Edinburgh’s School of Biological Sciences, who led the study; said; “The process of removing stalled proteins during production is there throughout nature, so we know that it is of fundamental importance to life. Greater knowledge of how this occurs could potentially aid progress in the understanding of many diseases.”